| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/28/2010 | WO2009147441A3 Novel treatments |
| 01/28/2010 | WO2009125987A9 Pharmaceutical formulation |
| 01/28/2010 | WO2009124962A3 Sulfonamides |
| 01/28/2010 | WO2009118753A3 Process for preparation of naratriptan hydrochloride |
| 01/28/2010 | WO2009102966A3 Bmp-7 for use in treating vascular sclerosis |
| 01/28/2010 | WO2009047826A8 Pharmaceutical composition comprising sucralphate and mesalazine |
| 01/28/2010 | WO2009027849A3 Guava extract |
| 01/28/2010 | WO2009009768A8 METHODS OF INHIBITING THE FORMATION OF AMYLOID-β DIFFUSABLE LIGANDS USING A ACYLHYDRAZIDE COMPOUNDS |
| 01/28/2010 | US20100022747 Prophylactic agent for heart failure |
| 01/28/2010 | US20100022657 Treatment of faecal incontinence and other conditions with 1R, 2S-methoxamine |
| 01/28/2010 | US20100022643 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 01/28/2010 | US20100022638 Isosorbide nitrates |
| 01/28/2010 | US20100022602 Pre-mixed, ready-to-use iv bolus nicardipine compositions and methods of use |
| 01/28/2010 | US20100022591 Piperidine gpcr agonists |
| 01/28/2010 | US20100022582 Tetrahydroisoquinoline Compound and Medicinal Use Thereof |
| 01/28/2010 | US20100022581 Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinity |
| 01/28/2010 | US20100022572 Novel spiro compound and medicine comprising the same |
| 01/28/2010 | US20100022556 Therapeutic combinations comprising a long acting dihydropyridine calcium-channel blocker and a statin |
| 01/28/2010 | US20100022552 Kmup-1 capable of treating hypertension |
| 01/28/2010 | US20100022537 I-pheny 1-3,4-dihydropyrimidin-2(1h)-one derivatives and their use |
| 01/28/2010 | US20100022502 Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases |
| 01/28/2010 | US20100022498 Steroids as agonists for fxr |
| 01/28/2010 | US20100022497 Method for treating or preventing a cardiovascular disease or condition utilizing estrogen receptor modulators based on APOE allelic profile of a mammalian subject |
| 01/28/2010 | US20100022486 Compounds |
| 01/28/2010 | US20100022484 4-Chromenonyl-1,4-dihydropyridines and their use |
| 01/28/2010 | US20100022473 Use of lipid conjugates in the treatment of diseases associated with vasculature |
| 01/28/2010 | US20100022464 Functional food composition that is rich in phenolic compounds and use of said composition |
| 01/28/2010 | US20100022448 Peptides |
| 01/28/2010 | US20100021573 Compositions and methods for the prevention of cardiovascular disease |
| 01/28/2010 | US20100021566 Reverse vitamin k effect via photodynamic oxidation targeted at vascular endothelium, fibrin and blood platelets |
| 01/28/2010 | US20100021524 Pimethixene derivatives for promoting bone growth |
| 01/28/2010 | US20100021519 Compositions and Methods for Treating or Preventing Diseases of Body Passageways |
| 01/28/2010 | US20100021482 Novel death associated proteins, and thap1 and par4 pathways in apoptosis control |
| 01/28/2010 | US20100021393 Pharmaceutical Compositions Comprising Effervescent Agents and Fenofibrate |
| 01/28/2010 | CA2731789A1 Alkyl thiazole carbamate derivatives, preparation thereof, and use thereof as faah enzyme inhibitors |
| 01/28/2010 | CA2731574A1 Isosorbide nitrates having vasodilating activity |
| 01/28/2010 | CA2731242A1 Compositions and methods related to sirt1 function |
| 01/27/2010 | EP2147930A2 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/27/2010 | EP2147929A2 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/27/2010 | EP2147928A2 Peptide-based immunization therapy for treatment of atherosclerososis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/27/2010 | EP2147683A1 Construct and method for the internalization of cargo molecules into a cell |
| 01/27/2010 | EP2147680A2 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/27/2010 | EP2147679A2 Compositions and methods for modulating blood-brain barrier transport |
| 01/27/2010 | EP2147673A1 Modulation of prostaglandin/cyclooxygenase metabolic pathways |
| 01/27/2010 | EP2146988A1 New 4,8-diphenyl-polyazanaphthalene derivatives |
| 01/27/2010 | EP2146963A2 Dual-acting antihypertensive agents |
| 01/27/2010 | EP2146948A1 Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease |
| 01/27/2010 | EP2146736A2 Modulators of vegf splicing as pro- and anti-angiogenic agents |
| 01/27/2010 | EP2146724A2 Role of hedgehog signaling in atherosclerosis and cardiovascular disease |
| 01/27/2010 | EP2146573A1 Unit dose formulations and methods of treating and preventing thrombosis with thromboxane receptor antagonists |
| 01/27/2010 | EP1732574B1 Use of o-atp for the treatment of diseases involving angiogenesis |
| 01/27/2010 | EP1438298B1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 01/27/2010 | EP1343485B1 Drug delivery system comprising a lipid-based nitric oxide donor |
| 01/27/2010 | EP1303503B1 Aniline derivatives |
| 01/27/2010 | CN101633646A Salts of valsartan |
| 01/27/2010 | CN101633645A N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/27/2010 | CN101633644A N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/27/2010 | CN101632663A Novel molecular target for neurotoxicity |
| 01/27/2010 | CN100584954C Method for producing paeonin metabolite-I by short lactobacillin fermentation |
| 01/27/2010 | CN100584945C Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 01/27/2010 | CN100584851C Phosphates of secondary alcohols |
| 01/27/2010 | CN100584819C Substituted 4-aminocyclohexanol derivatives |
| 01/27/2010 | CN100584382C Medicinal composition containing angiotensin II receptor agonist and fibric acid compound |
| 01/27/2010 | CN100584373C Preparation process of medicine for treating cerebral apoplexy and its sequela |
| 01/27/2010 | CN100584372C External use traditional Chinese medicine ointment for treating heart diseases |
| 01/27/2010 | CN100584364C A blood circulation-invigorating tendon-strengthening capsule and preparation process thereof |
| 01/27/2010 | CN100584359C Medicine for treating fatness and its complication |
| 01/27/2010 | CN100584358C Traditional Chinese medicine composition for treating cardio cerebrovasculer disease and its preparations and preparation method |
| 01/27/2010 | CN100584357C Medicine composition containing borneol and musk |
| 01/27/2010 | CN100584356C Musk containing medicine composition |
| 01/27/2010 | CN100584350C Medicine for treating myocarditis |
| 01/27/2010 | CN100584347C Composition of notoginsen triterpenes and tanshinone IIA sodium sulfonate |
| 01/27/2010 | CN100584336C Medicinal compositions |
| 01/27/2010 | CN100584326C Function of stilbene oxygen acid or salt in preparing antiatheroscloresis medicament |
| 01/26/2010 | US7652155 Diamine derivative, production process therefor and antioxidant |
| 01/26/2010 | US7652054 Gastrointestinal disorders; cardiovascular disorders; dyspepsia;anticancer agents; antiulcer agents |
| 01/26/2010 | US7652045 Activator of peroxisome proliferator-activated receptor δ |
| 01/26/2010 | US7652038 Methods of reducing angiogenesis |
| 01/26/2010 | US7652035 CRF receptor antagonists and methods relating thereto |
| 01/26/2010 | US7652022 N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea; |
| 01/26/2010 | US7652019 5,6-trimethylenepyrimidin-4-one compounds |
| 01/26/2010 | US7652017 Therapy for central nervous system, brain disorders |
| 01/26/2010 | US7652006 Substituted 1(2H)-phthalazinones and pharmaceutical compositions thereof |
| 01/26/2010 | US7651997 Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them |
| 01/26/2010 | US7651461 Cardiac support with metallic structure |
| 01/26/2010 | CA2481012C Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 01/26/2010 | CA2470064C Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 01/26/2010 | CA2469380C Heteroaryl-substituted aminocyclohexane derivatives |
| 01/26/2010 | CA2456606C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 01/26/2010 | CA2434731C Modular infusion device and method |
| 01/26/2010 | CA2422889C Method for the treatment of neurological and neuropsychological disorders |
| 01/26/2010 | CA2393083C Use of hypoglycemic agent for treating impaired glucose metabolism |
| 01/26/2010 | CA2350031C N-arylsulfonylamino acid omega-amides |
| 01/26/2010 | CA2303934C Tetrazole-containing rapamycin analogs with shortened half-lives |
| 01/26/2010 | CA2299470C Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation |
| 01/26/2010 | CA2222524C Somatostatin peptides |
| 01/21/2010 | WO2010009207A1 Bicyclic heterocycle derivatives and their use as gpcr modulators |
| 01/21/2010 | WO2010009195A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
| 01/21/2010 | WO2010009183A1 Pyridone and pyridazone analogues as gpr119 modulators |
| 01/21/2010 | WO2010009120A2 Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents |